AGEN

Agenus · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Mon 20:54 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Agenus

Agenus (AGEN) is a biopharmaceutical company focused on developing and commercializing innovative therapies for cancer and other serious diseases, operating within the Healthcare sector.

HealthcareBiotechnologyPharmaceuticals

Ticker	AGEN
Name	Agenus
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

33.73

RSI (14)i

3.26

SMA 20i

3.69

SMA 50i

3.74

SMA 200i

0.00%

1di

-2.48%

1wi

-12.29%

1mi

4.54%

30d voli

7.06

52w highi

2.77

52w lowi

-55.52%

from highi

-0.12

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 258 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-08 10:27

The stock has been in a downtrend with recent close at 3.23, showing a decline from its previous highs. The lack of recent news or significant market events does not provide enough information to make a clear bullish or bearish call. Given the current price action and absence of new developments, maintaining a cautious stance seems prudent.

qwen2.5:3b